Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Medical Neurobiology, Department of Pharmaceutics, School of Pharmacy , Fudan University , Shanghai 200032 , China.
Department of Interventional Radiology , Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 , PR China.
ACS Appl Mater Interfaces. 2018 Mar 28;10(12):10398-10408. doi: 10.1021/acsami.8b01712. Epub 2018 Mar 13.
An ideal gene-carrying vector is supposed to exhibit outstanding gene-condensing capability with positively charged macromolecules to protect the carried gene during in vivo circulation and a rapid dissociation upon microenvironmental stimuli at the aimed sites to release the escorted gene. Currently, it still remains a challenge to develop an ideal gene carrier with efficient transfection ability and low toxicity for clinical applications. Herein, we have innovatively introduced a reactive oxygen species (ROS)-biodegradable boric acid ester linkage in elaborating the design of a gene carrier. In virtue of the featured intracellular characteristics such as the high level of ROS in tumor cells, an ROS-biodegradable electropositive polymer derived from branched polyethylenimine (BPEI) with a low molecular weight (1.2k) through a cross-linking reaction by the boric acid ester bond was developed in this study to achieve condensation and escorting of carried genes. Furthermore, the polymer was modified with substance P (SP) peptide as the targeting ligand through polyethylene glycol. The final fabricated SP-cross-linked BPEI/plasmid DNA nanoparticles exhibit favorable biocompatibility, ROS-cleavability, and fine targeting ability as well as high transfection efficiency compared with parental BPEI both in vitro and in vivo. SP-cross-linked BPEI/small interfering RNA (pololike kinase 1) polyplex possesses favorable gene-silencing effects in vitro and satisfactory antitumor ability in vivo. Hopefully, this novel cross-linked electropositive polymer may serve well as a safe and efficient gene-delivery vehicle in the clinic.
理想的基因载体应具有出色的基因浓缩能力,能够与带正电荷的大分子结合,在体内循环过程中保护携带的基因,并在靶向部位的微环境刺激下迅速解离,释放出所携带的基因。目前,开发具有高效转染能力和低毒性的理想基因载体仍然是一个挑战,难以满足临床应用的需求。在此,我们创新性地在基因载体的设计中引入了活性氧(ROS)可降解硼酸酯键。鉴于肿瘤细胞中 ROS 水平较高的独特细胞内特征,本研究通过硼酸酯键的交联反应,开发了一种源自支化聚乙烯亚胺(BPEI)的 ROS 可降解正电性聚合物(分子量为 1.2k),以实现携带基因的浓缩和传递。此外,聚合物通过聚乙二醇进行了物质 P(SP)肽的修饰,作为靶向配体。与亲本 BPEI 相比,最终制备的 SP 交联 BPEI/质粒 DNA 纳米粒在体外和体内均表现出良好的生物相容性、ROS 可切割性、精细靶向能力和高转染效率。SP 交联 BPEI/小干扰 RNA(pololike 激酶 1)聚集体在体外具有良好的基因沉默效果,在体内具有令人满意的抗肿瘤能力。希望这种新型交联正电性聚合物可作为一种安全有效的基因传递载体,应用于临床。